Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance

<p>Abstract</p> <p>Background</p> <p>Estimates of the prevalence of transmitted HIV drug resistance (TDR) in a population are derived from resistance tests performed on samples from patients thought to be naïve to antiretroviral treatment (ART). Much of the debate over...

Full description

Bibliographic Details
Main Authors: Castro Hannah, Pillay Deenan, Sabin Caroline, Dunn David T
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Medical Research Methodology
Online Access:http://www.biomedcentral.com/1471-2288/12/30
id doaj-0ab742eb79984db08e0424c22fe27e63
record_format Article
spelling doaj-0ab742eb79984db08e0424c22fe27e632020-11-24T22:24:34ZengBMCBMC Medical Research Methodology1471-22882012-03-011213010.1186/1471-2288-12-30Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistanceCastro HannahPillay DeenanSabin CarolineDunn David T<p>Abstract</p> <p>Background</p> <p>Estimates of the prevalence of transmitted HIV drug resistance (TDR) in a population are derived from resistance tests performed on samples from patients thought to be naïve to antiretroviral treatment (ART). Much of the debate over reliability of estimates of the prevalence of TDR has focused on whether the sample population is representative. However estimates of the prevalence of TDR will also be distorted if some ART-experienced patients are misclassified as ART-naïve.</p> <p>Methods</p> <p>The impact of misclassification bias on the rate of TDR was examined. We developed methods to obtain adjusted estimates of the prevalence of TDR for different misclassification rates, and conducted sensitivity analyses of trends in the prevalence of TDR over time using data from the UK HIV Drug Resistance Database. Logistic regression was used to examine trends in the prevalence of TDR over time.</p> <p>Results</p> <p>The observed rate of TDR was higher than true TDR when misclassification was present and increased as the proportion of misclassification increased. As the number of naïve patients with a resistance test relative to the number of experienced patients with a test increased, the difference between true and observed TDR decreased. The observed prevalence of TDR in the UK reached a peak of 11.3% in 2002 (odds of TDR increased by 1.10 (95% CI 1.02, 1.19, p(linear trend) = 0.02) per year 1997-2002) before decreasing to 7.0% in 2007 (odds of TDR decreased by 0.90 (95% CI 0.87, 0.94, p(linear trend) < 0.001) per year 2002-2007. Trends in adjusted TDR were altered as the misclassification rate increased; the significant downward trend between 2002-2007 was lost when the misclassification increased to over 4%.</p> <p>Conclusion</p> <p>The effect of misclassification of ART on estimates of the prevalence of TDR may be appreciable, and depends on the number of naïve tests relative to the number of experienced tests. Researchers can examine the effect of ART misclassification on their estimates of the prevalence of TDR if such a bias is suspected.</p> http://www.biomedcentral.com/1471-2288/12/30
collection DOAJ
language English
format Article
sources DOAJ
author Castro Hannah
Pillay Deenan
Sabin Caroline
Dunn David T
spellingShingle Castro Hannah
Pillay Deenan
Sabin Caroline
Dunn David T
Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
BMC Medical Research Methodology
author_facet Castro Hannah
Pillay Deenan
Sabin Caroline
Dunn David T
author_sort Castro Hannah
title Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
title_short Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
title_full Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
title_fullStr Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
title_full_unstemmed Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
title_sort effect of misclassification of antiretroviral treatment status on the prevalence of transmitted hiv-1 drug resistance
publisher BMC
series BMC Medical Research Methodology
issn 1471-2288
publishDate 2012-03-01
description <p>Abstract</p> <p>Background</p> <p>Estimates of the prevalence of transmitted HIV drug resistance (TDR) in a population are derived from resistance tests performed on samples from patients thought to be naïve to antiretroviral treatment (ART). Much of the debate over reliability of estimates of the prevalence of TDR has focused on whether the sample population is representative. However estimates of the prevalence of TDR will also be distorted if some ART-experienced patients are misclassified as ART-naïve.</p> <p>Methods</p> <p>The impact of misclassification bias on the rate of TDR was examined. We developed methods to obtain adjusted estimates of the prevalence of TDR for different misclassification rates, and conducted sensitivity analyses of trends in the prevalence of TDR over time using data from the UK HIV Drug Resistance Database. Logistic regression was used to examine trends in the prevalence of TDR over time.</p> <p>Results</p> <p>The observed rate of TDR was higher than true TDR when misclassification was present and increased as the proportion of misclassification increased. As the number of naïve patients with a resistance test relative to the number of experienced patients with a test increased, the difference between true and observed TDR decreased. The observed prevalence of TDR in the UK reached a peak of 11.3% in 2002 (odds of TDR increased by 1.10 (95% CI 1.02, 1.19, p(linear trend) = 0.02) per year 1997-2002) before decreasing to 7.0% in 2007 (odds of TDR decreased by 0.90 (95% CI 0.87, 0.94, p(linear trend) < 0.001) per year 2002-2007. Trends in adjusted TDR were altered as the misclassification rate increased; the significant downward trend between 2002-2007 was lost when the misclassification increased to over 4%.</p> <p>Conclusion</p> <p>The effect of misclassification of ART on estimates of the prevalence of TDR may be appreciable, and depends on the number of naïve tests relative to the number of experienced tests. Researchers can examine the effect of ART misclassification on their estimates of the prevalence of TDR if such a bias is suspected.</p>
url http://www.biomedcentral.com/1471-2288/12/30
work_keys_str_mv AT castrohannah effectofmisclassificationofantiretroviraltreatmentstatusontheprevalenceoftransmittedhiv1drugresistance
AT pillaydeenan effectofmisclassificationofantiretroviraltreatmentstatusontheprevalenceoftransmittedhiv1drugresistance
AT sabincaroline effectofmisclassificationofantiretroviraltreatmentstatusontheprevalenceoftransmittedhiv1drugresistance
AT dunndavidt effectofmisclassificationofantiretroviraltreatmentstatusontheprevalenceoftransmittedhiv1drugresistance
_version_ 1725760585081028608